The Alzheimer's Economy: Is It Worth $ 56,000 a Year in New Drugs?
Jeff Borghoff knew there was something wrong with his face creating a rumor and then falling apart. When he was just 51 years old when he received a d
Stay updated with breaking news from Jeff Borghoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jeff Borghoff knew there was something wrong with his face creating a rumor and then falling apart. When he was just 51 years old when he received a d
Studies have found that reducing plaque does not necessarily help patients with alzheimer's. last november dr. caleb alexander was on an f.d.a. advisory committee that voted against recommending approval. what are your objections to approval of this drug? >> well, i think the jury is still out on whether it works. and in this instance i think that the evidence is still quite murky as to the effectiveness of this product. was partially positive and >> reporter: aduhelm trials have had mixed outcomes for patients. >> one trial failed and one trial was partially positive and essentially that leav...